CellaVision AB (publ) (STO:CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
124.00
+1.40 (1.14%)
May 5, 2026, 1:32 PM CET

CellaVision AB Revenue

CellaVision AB had revenue of 166.43M SEK in the quarter ending March 31, 2026, a decrease of -14.57%. This brings the company's revenue in the last twelve months to 730.59M, down -2.32% year-over-year. In the year 2025, CellaVision AB had annual revenue of 758.97M with 4.94% growth.

Revenue (ttm)
730.59M
Revenue Growth
-2.32%
P/S Ratio
4.00
Revenue / Employee
3.03M
Employees
231
Market Cap
2.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025758.97M35.75M4.94%
Dec 31, 2024723.22M45.93M6.78%
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020471.44M9.67M2.09%
Dec 31, 2019461.77M96.96M26.58%
Dec 31, 2018364.81M55.50M17.94%
Dec 31, 2017309.31M44.27M16.70%
Dec 31, 2016265.04M25.65M10.71%
Dec 31, 2015239.39M22.47M10.36%
Dec 31, 2014216.92M37.07M20.61%
Dec 31, 2013179.85M10.34M6.10%
Dec 31, 2012169.51M14.11M9.08%
Dec 31, 2011155.40M23.76M18.05%
Dec 31, 2010131.64M22.66M20.80%
Dec 31, 2009108.97M8.53M8.49%
Dec 31, 2008100.44M25.88M34.71%
Dec 31, 200774.57M19.79M36.12%
Dec 31, 200654.78M15.76M40.39%
Dec 31, 200539.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nolato AB9.46B
Vitrolife AB3.41B
MedCap AB2.18B
BICO Group AB1.49B
Xvivo Perfusion AB834.53M
C-Rad AB441.90M
Paxman AB323.56M
Bactiguard Holding AB201.18M
Revenue Rankings